Body fat mass
3 papers1 finding
- Human trial2
- Humans1
Interventions
1Lactococcus lactis subsp. lactis
downin humans1
1 study
Lactococcus lactis subsp. lactis
downin humans1
Lactococcus lactis subsp. lactis decreases body fat mass in humans (-1.59 kg (95% CI -2.50 to -0.67)).
Human trialin overweight or obesitystrain CAB701150 mg/day12 weeksn = 100
Probiotics and antimicrobial proteins2 Sep 2026
Latest
21 in 12 monthsResearch Square
A 10-Week Community-Based Barefoot Walking Program: Mobility-Related Functional Outcomes and Selected Health Indicators in Older Adults — A Non-Randomized Controlled Study
Preprint: non-randomised trial in 25 peopleInterventions
Journal of Cachexia, Sarcopenia and Muscle
Age- and Sex-Specific Percentile Curves for the FM/FFM Ratio Using Data From the Canadian Longitudinal Study on Aging
Cross-sectional study of 28,791 peopleBiomarkers
International Journal of Obesity
Indirect comparative efficacy and safety of tirzepatide vs semaglutide for the treatment of obesity or overweight in patients without type 2 diabetes
Computational studyTirzepatide
Medical Sciences
A Six-Week Multimodal Functional Training Program Improves Physical Function and Modulates Redox Homeostasis in Older Women
Non-randomised trial in 17 peopleInterventions
Frontiers in Nutrition
Excessive weight loss during alternate day modified fasting increases the risk of hyperuricemia and muscle loss
Non-randomised trial in 35 peopleHyperuricemia
Frontiers in Endocrinology
Low baseline HbA1c and reduced eGFR are associated with relatively unfavorable body recomposition after SGLT2 inhibitor therapy in type 2 diabetes
Cohort study of 148 peopleSGLT2 inhibitors
Chronobiology International
Relationship between genetic risk, social jetlag, and obesity traits in a Turkish adult population
Cross-sectional study of 223 peopleObesity